Trent Miller

Trent Miller is an experienced Institutional Sales Specialist at BioXcel Therapeutics, Inc. since November 2022, focusing on securing hospital formulary approval for a sublingual film treating agitation associated with schizophrenia and bipolar disorders. Previous roles include Key Account Manager at Shionogi Inc., where positioning of a gram-negative antibiotic was managed, and Rare Disease Specialist at Akcea Therapeutics, specializing in ultra-rare diseases. Trent also served as a Territory Business Manager at Nabriva Therapeutics plc, managing hospital accounts, and as a Renal Account Specialist at Otsuka Pharmaceutical Companies, representing an orphan drug. Education includes a Bachelor's degree in Economics from the University of St. Thomas.